SS
VERA icon

Steve Schonfeld’s Vera Therapeutics VERA Stock Holding History

Steve Schonfeld’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,402
Closed -$1.64M – 2706
2025
Q4 		$1.64M Sell
32,402
-47,108
-59% -$1.67M 0.01% 943
2025
Q3 		$2.31M Sell
79,510
-65,315
-45% -$1.51M 0.01% 962
2025
Q2 		$3.41M Buy
144,825
+68,207
+89% +$1.53M 0.02% 720
2025
Q1 		$1.84M Sell
76,618
-40,297
-34% -$1.29M 0.01% 1004
2024
Q4 		$4.94M Sell
116,915
-79,435
-40% -$3.52M 0.03% 509
2024
Q3 		$8.68M Sell
196,350
-92,094
-32% -$3.49M 0.06% 337
2024
Q2 		$10.4M Buy
+288,444
New +$11.4M 0.07% 333

Other funds holding VERA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Steve Schonfeld's VERA Position: Q1 2026 in Review

Steve Schonfeld sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 32,402 shares — an estimated $1.64M sold.

Steve Schonfeld first reported a position in VERA in Q2 2024 and held it in 7 quarters. The position peaked at $10.4M in Q2 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Steve Schonfeld reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Steve Schonfeld sold 32,402 Vera Therapeutics shares in Q1 2026, an estimated $1.64M.
  • Steve Schonfeld first reported a position in Vera Therapeutics in Q2 2024 and held it in 7 quarters.
  • Steve Schonfeld's Vera Therapeutics position peaked at $10.4M in Q2 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.